US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Fidelity Disruptive Medicine ETF

32.26

-0.2659-0.82%

Post-market: 32.24-0.0230-0.07%19:30 EDT

Volume:5K

Turnover:159.94K

Market Cap:52.39M

PE:- -

High:32.47

Open:32.47

Low:32.03

Close:32.53

52wk High:32.89

52wk Low:23.48

Shares:1.62M

Float Shares:1.62M

Volume Ratio:0.55

T/O Rate:0.31%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

10x Genomics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

10x Genomics Q2 Revenue Rises on Atera Demand

10x Genomics Q2 Swings to Loss, Revenue Falls

MT Newswires Live

Canada's WELL Health Q2 Revenue Rises, Lifts 2026 Outlook

10x Genomics Q2 EPS $(0.14) Beats $(0.24) Estimate, Sales $151.000M Beat $146.788M Estimate

Benzinga Earnings

10X Genomics Q2 Revenue USD 151 Million Vs. IBES Estimate USD 146.8 Million

LifeStance Raises Fy2026 Revenue Outlook to $1.685 Billion-$1.725 Billion

LifeStance Health Group, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Lifestance Health Swings to Q2 Profit as Revenue Rises; Raises 2026 Revenue Guidance

MT Newswires Live

Lifestance Health Lifts Outlook After Strong Q2 Results

LifeStance Q2 FY26 Net Income Turns to USD 23.6 Million; Revenue Rises 26% to USD 435.4 Million

Lifestance Health Q2 Revenue USD 435.4 Million Vs. IBES Estimate USD 414.6 Million

Lifestance Health Q2 EPS USD 0.06

THOMSON REUTERS

Lifestance Health Group, - Approves New $100 Mln Share Repurchase Program

THOMSON REUTERS

Lifestance Health Outlook Q3 Revenue USD 420-440 Million

THOMSON REUTERS

Lifestance Health Group Inc Says Raising Full Year Revenue Outlook to $1.685 Bln to $1.725 Bln

THOMSON REUTERS

Lifestance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook

THOMSON REUTERS

LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook

Revvity Inc. Stock Outperforms Competitors on Strong Trading Day

Envista Q2 Sales Rise on Segments Growth

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/FMED/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","market":"US","secType":"STK","nameCN":"Fidelity Disruptive Medicine ETF","latestPrice":32.263,"timestamp":1787601600000,"preClose":32.5289,"halted":0,"volume":4957,"hourTrading":{"tag":"盘后","latestPrice":32.24,"preClose":32.263,"latestTime":"19:30 EDT","volume":9,"amount":290.367,"timestamp":1787614203815,"change":-0.023,"changeRate":-0.000713,"amplitude":0},"delay":0,"changeRate":-0.008174269649450243,"floatShares":1623806,"shares":1623806,"eps":0,"marketStatus":"Not Yet Opened","change":-0.2659,"latestTime":"08-24 16:00:00 EDT","open":32.47,"high":32.47,"low":32.03,"amount":159940.004188,"amplitude":0.013526,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":32.5289,"sharesOutstanding":2323806,"nav":32.59815,"aum":52933071.5589,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":32.24,"preClose":32.263,"latestTime":"19:30 EDT","volume":9,"amount":290.367,"timestamp":1787614203815,"change":-0.023,"changeRate":-0.000713,"amplitude":0},"volumeRatio":0.550974,"impliedVol":0.0806,"impliedVolPercentile":0.2229},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FMED\",,,,,undefined,":{"symbol":"FMED","floatShares":1623806,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.550974,"shares":1623806,"dividePrice":0,"high":32.47,"amplitude":0.013526,"preClose":32.5289,"low":32.03,"week52Low":23.48,"pbRate":"--","week52High":32.8877,"institutionHeld":0,"latestPrice":32.263,"eps":0,"divideRate":0,"volume":4957,"delay":0,"ttmEps":0,"open":32.47,"prevYearClose":27.05,"prevWeekClose":32.5289,"prevMonthClose":27.9952,"prevQuarterClose":28.525,"fiveDayClose":30.5871,"twentyDayClose":28.3719,"sixtyDayClose":25.2617},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FMED\",params:#limit:5,,,undefined,":[{"date":"2024-12-20","symbol":"FMED","amount":0.112,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-24"},{"date":"2024-06-21","symbol":"FMED","amount":0.001,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-21","defaultRemindTime":1718976600000,"name":"Fidelity Disruptive Medicine ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-25","payableDate":"2024-06-21","currency":"USD","dateTimestamp":1718942400000,"payDate":"2024-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FMED\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-21","recordDate":"2024-06-21","paymentDate":"2024-06-25","value":0.001,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-24","value":0.112,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FMED\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657775663","title":"10x Genomics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657775663","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657775663?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:01","pubTimestamp":1786050098,"startTime":"0","endTime":"0","summary":"10x Genomics, Inc. reports results for the quarter ended June 30 - Earnings Summary10x Genomics, Inc.TXG.OQreported a quarterly adjusted loss of 14 cents per share for the quarter ended June 30, lower","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4433DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","BK4588","LU1861559042.SGD","FMED","LU1861558580.USD","TXG","BK4121","BK4585","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650213","title":"10x Genomics Q2 Revenue Rises on Atera Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650213","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650213?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:22","pubTimestamp":1786047738,"startTime":"0","endTime":"0","summary":"10x Genomics Q2 revenue rises on Atera demandOverviewUS life science tools firm's Q2 revenue rose 3% yr/yr, beating analyst expectationsCompany posted Q2 net loss as operating expenses rose on lower s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431DX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","LU1861559042.SGD","BK4121","BK4585","TXG","BK4539","PACB","BK4588","CTKB","FMED","BK4548","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657668345","title":"10x Genomics Q2 Swings to Loss, Revenue Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2657668345","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657668345?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:19","pubTimestamp":1786047548,"startTime":"0","endTime":"0","summary":"10x Genomics  reported a Q2 loss late Thursday of $0.14 per diluted share, swinging from earnings of $0.28 a year earlier.Analysts polled by FactSet expected a loss of $0.24.Revenue for the quarter ended June 30 was $151.0 million, down from $172.9 million a year earlier.Analysts expected $146.7 million.For full-year 2026, the company now expects revenue of $610 million to $630 million, up from its prior guidance of $600 million to $625 million. Analysts expect $613.7 million.Shares of 10x Genomics were down nearly 3% in after-hours activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FMED","BK4548","LU1861558580.USD","BK4588","ARKG","BK4121","LU1861559042.SGD","TXG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657657748","title":"Canada's WELL Health Q2 Revenue Rises, Lifts 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657657748","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657657748?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:10","pubTimestamp":1786047011,"startTime":"0","endTime":"0","summary":"Canada's WELL Health Q2 revenue rises, lifts 2026 outlookOverviewCanada digital healthcare firm's Q2-2026 revenue rose 12% yr/yr, driven by Canadian Patient ServicesAdjusted EBITDA fell 3% due to prio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LFST","PRVA","FMED","BK4581","BK4535","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657657513","title":"10x Genomics Q2 EPS $(0.14) Beats $(0.24) Estimate, Sales $151.000M Beat $146.788M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657657513","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657657513?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:05","pubTimestamp":1786046746,"startTime":"0","endTime":"0","summary":"10x Genomics (NASDAQ:TXG) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.24) by 41.67 percent. This is a 150 percent decrease over earnings of $0.28 per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61017245/10x-genomics-q2-eps-0-14-beats-0-24-estimate-sales-151-000m-beat-146-788m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"10x Genomics Q2 EPS $(0.14) Beats $(0.24) Estimate, Sales $151.000M Beat $146.788M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","LU1861558580.USD","BK4588","BK4548","LU1861559042.SGD","BK4585","BK4121","TXG","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657065205","title":"10X Genomics Q2 Revenue USD 151 Million Vs. IBES Estimate USD 146.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657065205","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657065205?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:03","pubTimestamp":1786046580,"startTime":"0","endTime":"0","summary":"BRIEF-10X Genomics Q2 Revenue USD 151 Million Vs. IBES Estimate USD 146.8 MillionAug 06 (Reuters) - 10X Genomics Q2 operating income USD -19.6 million.Q2 net income USD -17.9 millionQ2 gross margin 74%outlook FY revenue USD 610-630 million vs. IBES estimate USD 613.9 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXVGJWS3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","BK4548","BK4121","LU1861559042.SGD","BK4585","BK4588","FMED","ARKG","TXG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657658017","title":"LifeStance Raises Fy2026 Revenue Outlook to $1.685 Billion-$1.725 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2657658017","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657658017?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:07","pubTimestamp":1786028855,"startTime":"0","endTime":"0","summary":"LifeStance raises FY2026 revenue outlook to $1.685 billion-$1.725 billionLifeStance raised full-year 2026 revenue guidance to $1.685-$1.725 billion, a $45 million midpoint increase, implying 20% growt","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL23NJdV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","LFST","BK4539","FMED","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657763217","title":"LifeStance Health Group, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657763217","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657763217?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:31","pubTimestamp":1786023095,"startTime":"0","endTime":"0","summary":"LifeStance Health Group, Inc. reports results for the quarter ended June 30 - Earnings SummaryLifeStance Health Group, Inc.LFST.OQreported quarterly adjusted earnings of 6 cents per share for the quar","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4431US:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMED","LFST","BK4539","BK4196","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657680368","title":"Lifestance Health Swings to Q2 Profit as Revenue Rises; Raises 2026 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2657680368","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657680368?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:48","pubTimestamp":1786013305,"startTime":"0","endTime":"0","summary":"Lifestance Health Group  reported Q2 earnings Thursday of $0.06 per diluted share, swinging from a loss of $0.01 a year earlier.Four analysts polled by FactSet expected $0.04.Revenue for the quarter ended June 30 was $435.4 million, up from $345.3 million a year earlier.Analysts surveyed by FactSet expected $414.6 million.The mental health services provider expects Q3 revenue of between $420 million and $440 million. Analysts polled by FactSet expect $418.5 million.For 2026, the company raised its revenue guidance to $1.685 billion to $1.725 billion, from the prior guidance of $1.64 billion to $1.68 billion. Analysts surveyed by FactSet expect $1.66 billion.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LFST","BK4535","BK4196","BK4539","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657687226","title":"Lifestance Health Lifts Outlook After Strong Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657687226","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657687226?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:41","pubTimestamp":1786012882,"startTime":"0","endTime":"0","summary":"Lifestance Health Group ( ($LFST) ) has provided an announcement. LifeStance Health Group reported strong second-quarter 2026 results on August 6, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lifestance-health-lifts-outlook-after-strong-q2-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lifestance-health-lifts-outlook-after-strong-q2-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LFST","BK4535","BK4196","BK4539","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657682535","title":"LifeStance Q2 FY26 Net Income Turns to USD 23.6 Million; Revenue Rises 26% to USD 435.4 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657682535","media":"Reuters","labels":["shareholding","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657682535?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:13","pubTimestamp":1786011204,"startTime":"0","endTime":"0","summary":"LifeStance Q2 FY26 net income turns to USD 23.6 million; revenue rises 26% to USD 435.4 millionLifeStance posted Q2 2026 revenue of $435.4 million, up 26% from the prior-year quarter.Net income swung ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL2Lkslq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4196","BK4539","FMED","LFST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657684161","title":"Lifestance Health Q2 Revenue USD 435.4 Million Vs. IBES Estimate USD 414.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657684161","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657684161?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:01","pubTimestamp":1786010465,"startTime":"0","endTime":"0","summary":"BRIEF-Lifestance Health Q2 Revenue USD 435.4 Million Vs. IBES Estimate USD 414.6 MillionAug 06 (Reuters) - Lifestance Health Q2 adjusted EBITDA USD 66 million vs. IBES estimate USD 54.2 million.Q2 net income USD 23.6 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXJ80WRB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4196","LFST","FMED","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657844786","title":"Lifestance Health Q2 EPS USD 0.06","url":"https://stock-news.laohu8.com/highlight/detail?id=2657844786","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657844786?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:00","pubTimestamp":1786010405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXJ80WRB:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","LFST","BK4196","FMED","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657684473","title":"Lifestance Health Group, - Approves New $100 Mln Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2657684473","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657684473?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:00","pubTimestamp":1786010405,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXJ80WRB:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","LFST","FMED","BK4535","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657684297","title":"Lifestance Health Outlook Q3 Revenue USD 420-440 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657684297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657684297?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:00","pubTimestamp":1786010405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXJ80WRB:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","FMED","BK4196","BK4535","LFST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657684295","title":"Lifestance Health Group Inc Says Raising Full Year Revenue Outlook to $1.685 Bln to $1.725 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2657684295","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657684295?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:00","pubTimestamp":1786010405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXJ80WRB:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FMED","BK4539","BK4535","LFST","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657868450","title":"Lifestance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657868450","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657868450?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:00","pubTimestamp":1786010405,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUA8RCSCS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4535","FMED","LFST","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657687349","title":"LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657687349","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657687349?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:00","pubTimestamp":1786010400,"startTime":"0","endTime":"0","summary":"Announces $100 Million Share Repurchase ProgramSCOTTSDALE, Ariz., Aug.  06, 2026  (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/06/3340025/0/en/LifeStance-Reports-Strong-Second-Quarter-2026-Financial-Results-and-Raises-Full-Year-Outlook.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LFST","BK4196","BK4535","FMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657057935","title":"Revvity Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2657057935","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657057935?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:16","pubTimestamp":1785964560,"startTime":"0","endTime":"0","summary":"DJ Revvity Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Revvity Inc.  advanced 3.26% to $115.02 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.49% to 54,349.12 and the S&P 500 Index  falling 0.17% to 7,723.55.Revvity Inc. closed 2.77% short of its 52-week high of $118.30, which the company achieved on January 22nd.The stock outperformed some of its competitors Wednesday, as Danaher Corp.  rose 2.51% to $199.66, IDEXX Laboratories Inc.  fell 0.56% to $584.78, and Agilent Technologies Inc.  rose 1.37% to $141.11.Trading volume  eclipsed its 50-day average volume of 1.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 5, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","BK4504","GB00B4QBRK32.GBP","LU0122379950.USD","IE00BZ1G4Q59.USD","LU0882574055.USD","LU2092937221.SGD","LU0114720955.EUR","SGXZ23171101.USD","RVTY","LU0312595415.SGD","LU2404859667.USD","LU0289739343.SGD","LU0690374961.EUR","BK4567","LU1791710582.SGD","FMED","IE0004445239.USD","LU0289960550.SGD","LU1974910355.USD","LU2211814178.USD","LU0390134368.USD","SG9999013999.USD","PAWZ","LU2041044095.USD","IE00BKVL7J92.USD","A","LU2125910336.SGD","BK4585","IE00BQXX3F31.USD","IE00B64QTZ34.USD","LU1551013342.USD","GB00B4LPDJ14.GBP","SG9999001176.SGD","LU2125909247.SGD","DHR","LU0345774631.USD","BK4121","LU0187121727.USD","LU2023250504.SGD","LU0820561909.HKD","LU1917777945.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU0672654240.SGD","IDXX","LU0708995401.HKD","LU1721429402.USD","LU2125909593.SGD","LU2125910179.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657573001","title":"Envista Q2 Sales Rise on Segments Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2657573001","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657573001?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:40","pubTimestamp":1785962415,"startTime":"0","endTime":"0","summary":"Envista Q2 sales rise on segments growthOverviewUS dental products maker's Q2 sales rose yr/yr, beating analyst expectationsAdjusted diluted EPS for Q2 rose 58% yr/yr to $0.41Company raised full-year ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930573.SGD","LU0211327993.USD","NVST","LU1023059063.AUD","LU0006061336.USD","FMED","LU0130102774.USD","IE0004445239.USD","LU0109391861.USD","LU0175139822.USD","LU0889566641.SGD","IE000M9KFDE8.USD","LU2355687059.USD","IE0034390439.USD","LU0130517989.USD","IE00BQXX3C00.GBP","LU0648000940.SGD","LU1804176565.USD","LU1267930813.SGD","LU0029864427.USD","LU0390134368.USD","LU0792757196.USD","SGXZ57979304.SGD","LU0528227936.USD","LU2112291526.USD","LU0477156953.USD","LU0122379950.USD","LU1201861165.SGD","ZBH","BK4533","LU0648001328.SGD","LU0097036916.USD","LU2125909247.SGD","LU2023250504.SGD","IE00B19Z3581.USD","LU2106854487.HKD","LU1551013342.USD","LU1551013425.SGD","LU0114720955.EUR","LU1974910355.USD","DHR","LU0107464264.USD","HSIC","LU1917777945.USD","LU0320765059.SGD","LU0477156797.USD","LU1267930730.SGD","BK4175","IE00BQXX3F31.USD","LU0820562030.AUD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}